Unio Health Partners’ Post

Anyone actively managing their career should constantly be evaluating which markets, verticals, categories or products are going to be red hot for the foreseeable future. The easiest way to do so is to follow the $$$: -> Where are the large strategics investing M&A dollars? -> Where are VC/PE firms placing bets? -> Lastly, and maybe most importantly, where is CMS driving reimbursement? Wherever CMS goes, commercial payers will follow. Strong reimbursement drives demand for specific procedures/therapies, which increases utilization of associated technologies. For example, the Peripheral Atherectomy heyday (roughly 2010-2020) was preceded by CMS's announcement that they were enhancing reimbursement to north of $15K for procedures done in the outpatient setting. This set off several nationwide trends. It was boomtown for the Peripheral Atherectomy. It also triggered a nationwide wave of Interventional Cardiologists, Interventional Radiologists, and even some Vascular Surgeons who opened Office Based Interventional Labs. For a mere $1.8M investment to retrofit an office, a Physician could be equipped to do these interventional procedures in their office instead of the hospital, allowing them to capture the monies associated with this procedure. Another example is the recent run on Pulmonary Embolism Thrombectomy. As reimbursement for this procedure steadily increased, so too did the attention it got from from early stage companies and large strategics alike. Last time I checked, roughly a year ago...there were 58 companies that either had an FDA approved device, or were actively pursuing the indication. Directing one's career where capital is flowing allows individuals to draft off the following tailwinds: -> Increased device utilization, which leads to... -> Growth of the companies making these technologies, which leads to... -> Expansion of the operating teams, which leads to... -> Opportunities for career growth and advancement. The first rule of career advancement is to get on with a company that will experience growth, thereby necessitating expansion. Are you currently in a stagnant, or worse...contracting market? Is reimbursement being cut for the procedures you are selling in? If so, it may be worth taking an career inventory. Perhaps a pivot might be worth considering? If not, regardless of one's performance, the opportunities for advancement might be limited for the foreseeable future.

As our organization surges towards our 30th year of serving the New England #medtech ecosystem, we are thrilled to announce new additions to our Board of Directors. The board includes senior leaders ranging from the largest medical technology companies in the world, to the most cutting-edge companies in the region, representing the most diverse board in the organization's history, and positioning the organization to continue its unprecedented growth moving into its 30th year of serving the #medtech community. Having served the organization for more than five years, we are proud to announce that Todd Usen, President & CEO of Minerva Surgical, Inc. has been elected as the Chair of our Board of Directors for 2024-2025. His proven record of accomplishment, leading large, complex global businesses across several highly regarded medical device companies will be extremely beneficial to the organization and ecosystem. The Board of Directors has also approved two new members of its Executive Committee: Diana Gelston, Chief Commercial Officer, Best Buy Health and Devi Govender, Platform President, Abiomed, part of Johnson & Johnson MedTech. The expanded Executive Committee will provide the organization with leadership continuity and the capacity for future growth, as it prepares for its 30th anniversary in 2026. Congratulations as well to the new members of our Board of Directors, including: - Desmond Adler, PhD, President, Gentuity, LLC - Matthew Boyd, Chief Commercial Officer, Boyd Biomedical - Robert Chisena, Co-Founder & Chief Technology Officer, Amplitude Vascular Systems (AVS) - Rebecca Fahrig, Head of Business Line EVR & VP of Innovation, Business Area Advanced Therapies, Siemens Healthineers - Michael Ferguson, PhD, Vice President, Global Healthcare Economics and Reimbursement, AtriCure, Inc. - Nan-Wei Gong, PhD, Founder and CEO, FIGUR8, Inc. - Devi Govender, Platform President, Abiomed, part of Johnson & Johnson MedTech - Anh Hoang-Lindsay, PhD, CEO, Jana Care - Rajit Kamal, Vice President & General Manager, Surgical Robotics, Medtronic - Julie Khani, Corporate Vice President, Government Affairs and Corporate Communications, Hologic, Inc. - Michael E. Lyman, Vice President, Sales & Marketing, KARL STORZ United States - Mary Beth Moynihan, Senior Vice President, Market Access and Chief Marketing Officer, Boston Scientific - Stephanie Nelson Wimmer, MBA, MPH, Global Vice President, Health Economics, Market Access and Reimbursement (HEMAR), Philips - Alex Rodero, Vice President, Finance, Werfen - Carolina Säve, Of Counsel, Mintz Read more here: https://bit.ly/3xn7hDJ #Welcome #NewBoardMembers

Big News in MedTech: Merit Medical Acquires Cook's Lead Management Business! 💼💥 Exciting times in the medtech world as Merit Medical Systems just announced a $210M cash deal to acquire Cook Medical's lead management portfolio. This significant acquisition includes devices and accessories vital for procedures involving pacemakers and implantable cardioverter-defibrillator leads. Merit anticipates this deal will bolster their annual sales by $40 million, solidifying their stronghold in the competitive cardiac intervention market. This move is part of Merit's broader strategy to enhance their electrophysiology (EP) and cardiac rhythm management (CRM) offerings, key areas they view as high-margin growth opportunities. The added portfolio from Cook generated around $37 million last year, with robust sales coming from the U.S. and EMEA regions. By 2025, Merit projects their combined EP and CRM revenue will exceed $100 million annually. For those in the life sciences sector, these shake-ups present both challenges and opportunities. It underscores the importance of agility and innovative thinking in our industry. If you're navigating similar transitions or looking for top talent to steer your organisation through such changes, our team at Life Sciences Recruitment Ltd (LSR) is here to support your journey. Let's foster growth and innovation together. Feel free to reach out to me at luke.mcclean@lifescirecruitment.com for a chat about how we can help you find the right talent for your organisation. #MedTech #LifeSciences #Recruitment

🌟 Driving Innovation in Cardiology through Cross-Functional Leadership In the dynamic realm of cardiology, harnessing the power of cross-functional leadership is crucial for successful business development. By uniting diverse teams with unique expertise, we can drive innovation, deliver impactful solutions, and advance the healthcare industry. 🔑 Why Cross-Functional Leadership Matters: - Collaborative Innovation: Integrating insights from various functional partners to develop comprehensive strategies. - Enhanced Efficiency: Streamlining processes, reducing silos, and fostering a culture of collaboration. - Holistic Problem-Solving: Tackling challenges from multiple angles for robust solutions. - Customer-Centric Approach: Ensuring strategies are deeply rooted in understanding patient needs. 🌍 Business Development in Cardiology: Driving business development involves strategic market analysis, innovative go-to-market strategies, building strong partnerships, and continuous improvement. 🔧 Case in Point: At Medtronic, transforming sales operations led to significant growth through collaboration with cross-functional teams. 💡 Looking Ahead: Leveraging cross-functional leadership is vital for unlocking new levels of growth and excellence in cardiology innovation. Let's connect and drive the future of cardiology together! #BusinessDevelopment #Cardiology #CrossFunctionalLeadership #HealthcareInnovation #MedTech #CollaborativeLeadership #PatientCentric #HealthcareExcellence

Operating Room Integration Market worth $3.7 billion by 2028 Download PDF Brochure https://lnkd.in/dHaSn8Nb The global operating room integration market in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $3.7 billion by 2028, growing at a CAGR of 12.1% from 2023 to 2028. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Stryker (US), STERIS (US), KARL STORZ (Germany), Olympus Corporation (Japan), Getinge (Sweden). 𝐎𝐭𝐡𝐞𝐫 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Hillrom Barco Sony Skytron, TRUMPF Medical Systems Drägerwerk AG & Co. KGaA Arthrex Richard Wolf GmbH Smith+Nephew Zimmer Biomet CONMED Corporation Mizuho OSI Integra LifeSciences Holdings SAS EIZO Ampronix NDS Surgical Imaging Becton, Dickinson and Company Mindray Canon Medical Systems Corporation Smiths Medical Carestream Health India Pvt. Ltd. Philips FUJIFILM Holdings Corporation Alcon Laboratories (I) Private Limited, Boston Scientific Medtronic Johnson & Johnson GE HealthCare Masimo Schneider Electric Panasonic Avante Health Solutions Belimed Richardson Healthcare Ansell Occupational Healthcare #OperatingRoomIntegration #SurgicalInnovation #HealthcareTechnology #MedTech #ORIntegration

Pharma and Healthcare Industry Analysis - 2030 By 2030, the pharmaceutical and healthcare industry is projected to grow substantially, with a compound annual growth rate (CAGR) expected to exceed 5%. This growth is driven by increasing global healthcare expenditure, anticipated technological advancements in AI and biotechnology, and expanding healthcare infrastructure in both developed and emerging markets. Regulatory reforms aimed at enhancing drug approval processes and improving patient access to innovative therapies are also contributing factors. Furthermore, the industry's pivot towards personalized medicine and digital health solutions is set to transform patient care delivery, emphasizing improved outcomes and cost-effectiveness. Overall, the sector is poised for robust expansion, supported by innovations and strategic investments, promising significant opportunities and advancements by 2030. Top Companies in Pharma and Healthcare ➢ Talent Retriever ➢ Utah Business ➢ RA Capital Management ➢ NABLA Cosmetics ➢ MBH Architects ➢ Forefront ➢ Fruit Street ➢ Davis Furniture ➢ NexHealth ➢ Mach7 Technologies ➢ Center for Economic and Policy Research ➢ Skender ➢ Search Wizards ➢ DeAngelis Diamond ➢ DeepTek ➢ American Association of Nurse Anesthesiology (AANA) ➢ Hospital 2020 ➢ HiLabs ➢ Optizm Global ➢ Cogitativo ➢ IMO Health ➢ Coyne PR ➢ Stellar Global Solutions ➢ Current Electric ➢ Congress of Neurological Surgeons (CNS) ➢ Canopy One Solutions Inc ➢ Boston Technology Corporation ➢ National Quality Forum (NQF) ➢ PeopleLink Collaboration Inc. ➢ JK Executive Strategies, LLC ➢ Consilium Staffing ➢ SteadyMD ➢ Lexington Medical Center ➢ OpenSesame ➢ Argo Group ➢ Catamount Constructors ➢ Vytalize Health ➢ The Maxis Group ➢ Empowered Staffing ➢ Doster Construction Company #Pharma #Healthcare #Pharmaceuticals #Biotechnology #MedicalDevices #HealthTech #ClinicalTrials #HealthcareInnovation #DrugDiscovery #MedicalResearch #HealthcareIT #DigitalHealth #PatientCare #Biopharma #PrecisionMedicine #HealthcareAnalytics #PharmaMarketing #HealthcareProfessional #HealthPolicy #PharmaIndustry

I’m pleased to announce a solid execution for our first fiscal quarter, with a strong tailwinds throughout all aspects of our business. So, what were some of the Q1 highlights?     💪 We remain focused on growing the Company’s top-line while simultaneously improving our profitability metrics. 💪 Generated Record Revenues with Robust 37% Year-over-Year Revenue Growth in Q1 2024. 💪 Generated Positive Quarterly Net Income and positive cash flow from operations. 🚀 another record-breaking quarter in systems shipments. A net total of 57 systems, bringing BrainsWay’s total Deep TMS installed base to 1,158 systems. 🚀 Demand for the #OCD treatment indication continues to grow! 🤝 Expanded strategic partnership with enterprise accounts and growing TMS network in U.S: Katie’s Way Plus recently ordered an additional 18 Deep TMS systems and will now have an extensive network of approximately 40 devices.    🌍 Our international business continues to thrive: We expanded the availability of our Deep TMS technology in Israel, with most recent delivery of 11 systems in this country. 🤝 Achieved significant progress in advancing the science of Deep TMS in various potential future applications. Published paper in Human Neuroscience highlighted the results from multiple trials on Deep TMS as a potentially novel therapeutic approach for Parkinson's Disease. Published paper in the Journal of Clinical Medicine highlighting Deep TMS for the potential treatment of late-life depression, including positive clinical data from a post-marketing study. 🤝 Appointed Dr. Gilead Moiseyev as Chief Technology Officer. Dr. Moiseyev has over 20 years of experience in the medical device industry, with a substantial portion of that time spent leading R&D efforts at multiple companies. He will be critical in our efforts to expand BrainsWay’s innovative technology platform. 🤝 Appointed Ms. Honny Groen as Vice President of International Sales. Honny has over three decades of experience in global sales and business development within the medical technology industry, and she will be instrumental in advancing our efforts to expand BrainsWay’s global footprint.  🤝 Continued to achieve reimbursement progress, increasing access for patients to the #Deep TMS system. 💪 Based on our strong performance in Q1 2024, and our belief that this trend will continue, we anticipate that our profitability momentum and positive cash generation will continue throughout this year. I want to sincerely thank our talented and diverse group of employees for this success. I also want to thank our customers and investors for their confidence in BrainsWay. #neuromodulation #Brainsway #neuroscience #mentalhealth #mentalhealthawareness 

Pharma and Healthcare Industry Analysis - 2030 By 2030, the pharmaceutical and healthcare industry is projected to grow substantially, with a compound annual growth rate (CAGR) expected to exceed 5%. This growth is driven by increasing global healthcare expenditure, anticipated technological advancements in AI and biotechnology, and expanding healthcare infrastructure in both developed and emerging markets. Regulatory reforms aimed at enhancing drug approval processes and improving patient access to innovative therapies are also contributing factors. Furthermore, the industry's pivot towards personalized medicine and digital health solutions is set to transform patient care delivery, emphasizing improved outcomes and cost-effectiveness. Overall, the sector is poised for robust expansion, supported by innovations and strategic investments, promising significant opportunities and advancements by 2030. Top Companies in Pharma and Healthcare ➢ Talent Retriever ➢ University of Utah - David Eccles School of Business ➢ RA Capital Management ➢ Nabla ➢ MBH Architects ➢ Forefront ➢ Fruit Street ➢ Davis Furniture ➢ NexHealth ➢ Mach7 Technologies ➢ Center for Economic and Policy Research ➢ Skender ➢ Search Wizards ➢ DeAngelis Diamond ➢ DeepTek ➢ American Association of Nurse Anesthesiology (AANA) ➢ Hospital 2020 ➢ HiLabs ➢ Optizm Global ➢ Cogitativo ➢ IMO Health ➢ Coyne PR ➢ Stellar Global Solutions ➢ Current Executive Searches ➢ Congress of Neurological Surgeons (CNS) ➢ Canopy One Solutions Inc ➢ Boston Technology Corporation ➢ National Quality Forum (NQF) ➢ PeopleLink Collaboration Inc. ➢ JK Executive Strategies, LLC ➢ Consilium Staffing ➢ SteadyMD ➢ Lexington Medical Center ➢ OpenSesame ➢ Argo Group ➢ Catamount Constructors ➢ Vytalize Health ➢ The Maxis Group ➢ Empowered Staffing ➢ Doster Construction Company #Pharma #Healthcare #Pharmaceuticals #Biotechnology #MedicalDevices #HealthTech #ClinicalTrials #HealthcareInnovation #DrugDiscovery #MedicalResearch #HealthcareIT #DigitalHealth #PatientCare #Biopharma #PrecisionMedicine #HealthcareAnalytics #PharmaMarketing #HealthcareProfessional #HealthPolicy #PharmaIndustry

Pharma and Healthcare Industry Analysis - 2030 By 2030, the pharmaceutical and healthcare industry is projected to grow substantially, with a compound annual growth rate (CAGR) expected to exceed 5%. This growth is driven by increasing global healthcare expenditure, anticipated technological advancements in AI and biotechnology, and expanding healthcare infrastructure in both developed and emerging markets. Regulatory reforms aimed at enhancing drug approval processes and improving patient access to innovative therapies are also contributing factors. Furthermore, the industry's pivot towards personalized medicine and digital health solutions is set to transform patient care delivery, emphasizing improved outcomes and cost-effectiveness. Overall, the sector is poised for robust expansion, supported by innovations and strategic investments, promising significant opportunities and advancements by 2030. Top Companies in Pharma and Healthcare ➢ Talent Retriever ➢ University of Utah - David Eccles School of Business ➢ RA Capital Management ➢ Nabla ➢ MBH Architects ➢ Forefront ➢ Fruit Street ➢ Davis Furniture ➢ NexHealth ➢ Mach7 Technologies ➢ Center for Economic and Policy Research ➢ Skender ➢ Search Wizards ➢ DeAngelis Diamond ➢ DeepTek ➢ American Association of Nurse Anesthesiology (AANA) ➢ Hospital 2020 ➢ HiLabs ➢ Optizm Global ➢ Cogitativo ➢ IMO Health ➢ Coyne PR ➢ Stellar Global Solutions ➢ Current Executive Searches ➢ Congress of Neurological Surgeons (CNS) ➢ Canopy One Solutions Inc ➢ Boston Technology Corporation ➢ National Quality Forum (NQF) ➢ PeopleLink Collaboration Inc. ➢ JK Executive Strategies, LLC ➢ Consilium Staffing ➢ SteadyMD ➢ Lexington Medical Center ➢ OpenSesame ➢ Argo Group ➢ Catamount Constructors ➢ Vytalize Health ➢ The Maxis Group ➢ Empowered Staffing ➢ Doster Construction Company #Pharma #Healthcare #Pharmaceuticals #Biotechnology #MedicalDevices #HealthTech #ClinicalTrials #HealthcareInnovation #DrugDiscovery #MedicalResearch #HealthcareIT #DigitalHealth #PatientCare #Biopharma #PrecisionMedicine #HealthcareAnalytics #PharmaMarketing #HealthcareProfessional #HealthPolicy #PharmaIndustry

Pharma and Healthcare Industry Analysis - 2030 By 2030, the pharmaceutical and healthcare industry is projected to grow substantially, with a compound annual growth rate (CAGR) expected to exceed 5%. This growth is driven by increasing global healthcare expenditure, anticipated technological advancements in AI and biotechnology, and expanding healthcare infrastructure in both developed and emerging markets. Regulatory reforms aimed at enhancing drug approval processes and improving patient access to innovative therapies are also contributing factors. Furthermore, the industry's pivot towards personalized medicine and digital health solutions is set to transform patient care delivery, emphasizing improved outcomes and cost-effectiveness. Overall, the sector is poised for robust expansion, supported by innovations and strategic investments, promising significant opportunities and advancements by 2030. Top Companies in Pharma and Healthcare ➢ Talent Retriever ➢ University of Utah - David Eccles School of Business ➢ RA Capital Management ➢ Nabla ➢ MBH Architects ➢ Forefront ➢ Fruit Street ➢ Davis Furniture ➢ NexHealth ➢ Mach7 Technologies ➢ Center for Economic and Policy Research ➢ Skender ➢ Search Wizards ➢ DeAngelis Diamond ➢ DeepTek ➢ American Association of Nurse Anesthesiology (AANA) ➢ Hospital 2020 ➢ HiLabs ➢ Optizm Global ➢ Cogitativo ➢ IMO Health ➢ Coyne PR ➢ Stellar Global Solutions ➢ Current Executive Searches ➢ Congress of Neurological Surgeons (CNS) ➢ Canopy One Solutions Inc ➢ Boston Technology Corporation ➢ National Quality Forum (NQF) ➢ PeopleLink Collaboration Inc. ➢ JK Executive Strategies, LLC ➢ Consilium Staffing ➢ SteadyMD ➢ Lexington Medical Center ➢ OpenSesame ➢ Argo Group ➢ Catamount Constructors ➢ Vytalize Health ➢ The Maxis Group ➢ Empowered Staffing ➢ Doster Construction Company #Pharma #Healthcare #Pharmaceuticals #Biotechnology #MedicalDevices #HealthTech #ClinicalTrials #HealthcareInnovation #DrugDiscovery #MedicalResearch #HealthcareIT #DigitalHealth #PatientCare #Biopharma #PrecisionMedicine #HealthcareAnalytics #PharmaMarketing #HealthcareProfessional #HealthPolicy #PharmaIndustry